(VIANEWS) – New Residential Investment (NRZ), Ormat Technologies (ORA), IDEXX Laboratories (IDXX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. New Residential Investment (NRZ)
31.5% sales growth and 13.32% return on equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.32%.
2. Ormat Technologies (ORA)
18.1% sales growth and 4.45% return on equity
Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guadeloupe, Guatemala, Ethiopia, New Zealand, Honduras, and internationally. It operates through three segments: Electricity, Product, and Energy Storage. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic, and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and sells equipment for geothermal, recovered energy-based electricity generation; and provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy-based power plants. The Product segment serves contractors; developers, owners, and operators of geothermal power plants; and owners and operators of interstate natural gas pipelines, gas processing plants, and cement plants, as well as companies in other energy-intensive industrial processes. The Energy Storage segment offers energy storage and related services, as well as services relating to the engineering, procurement, construction, operation, and maintenance of energy storage units. Ormat Technologies, Inc. was founded in 1965 and is based in Reno, Nevada.
Earnings Per Share
As for profitability, Ormat Technologies has a trailing twelve months EPS of $1.54.
PE Ratio
Ormat Technologies has a trailing twelve months price to earnings ratio of 47.29. Meaning, the purchaser of the share is investing $47.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.45%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 14, 2023, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 0.65%.
Yearly Top and Bottom Value
Ormat Technologies’s stock is valued at $72.83 at 01:22 EST, way below its 52-week high of $101.81 and above its 52-week low of $72.64.
Volume
Today’s last reported volume for Ormat Technologies is 264512 which is 25.28% below its average volume of 354032.
3. IDEXX Laboratories (IDXX)
10.2% sales growth and 102.06% return on equity
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Earnings Per Share
As for profitability, IDEXX Laboratories has a trailing twelve months EPS of $9.39.
PE Ratio
IDEXX Laboratories has a trailing twelve months price to earnings ratio of 47.41. Meaning, the purchaser of the share is investing $47.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 102.06%.
Sales Growth
IDEXX Laboratories’s sales growth is 10.2% for the current quarter and 10.2% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 10.2% and 9.3%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
IDEXX Laboratories’s EBITDA is 144.94.
Yearly Top and Bottom Value
IDEXX Laboratories’s stock is valued at $445.21 at 01:22 EST, way below its 52-week high of $564.74 and way higher than its 52-week low of $317.06.
4. Sapiens International Corporation N.V. (SPNS)
9.7% sales growth and 14.19% return on equity
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. It also provides Sapiens DigitalSuite for insurance customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens AgentConnect and Sapiens CustomerConnect portals; Sapiens Intelligence, an analytics platform; Sapiens IntelligencePro, a comprehensive BI solution with pre-configured reports, dashboards, and scorecards; and Sapiens Advanced Analytics, which uses AI and Machine Learning to generate actionable insights based on different models across the insurance value chain. In addition, the company offers Sapiens ReinsuranceMaster, Sapiens ReinsurancePro, and Sapiens Reinsurance GO reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, Sapiens ClaimsGo, and Sapiens Connect for workers' compensation. Further, it provides financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Additionally, the company offers tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. It markets and sells its products and services through direct and partner sales. The company was founded in 1982 and is headquartered in Holon, Israel.
Earnings Per Share
As for profitability, Sapiens International Corporation N.V. has a trailing twelve months EPS of $1.02.
PE Ratio
Sapiens International Corporation N.V. has a trailing twelve months price to earnings ratio of 27.87. Meaning, the purchaser of the share is investing $27.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.19%.
Sales Growth
Sapiens International Corporation N.V.’s sales growth is 7.5% for the ongoing quarter and 9.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.2%, now sitting on 491.48M for the twelve trailing months.
Volume
Today’s last reported volume for Sapiens International Corporation N.V. is 96101 which is 32.09% below its average volume of 141525.
5. ExlService Holdings (EXLS)
9.4% sales growth and 22.55% return on equity
ExlService Holdings, Inc. operates as a data analytics, and digital operations and solutions company in the United States and internationally. It operates through Insurance, Healthcare, Analytics, and Emerging Business segments. The company provides digital operations and solutions and analytics-driven services across the insurance industry in areas, such as claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business acquisition, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer service using digital technology, artificial intelligence, machine learning, and advanced automation; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and LISS platforms; subrogation services; and Subrosource software platform, an end-to-end subrogation platform. It also offers CareRadius, an integrated care management offering; and health care services related to care management, utilization management, disease management, payment integrity, revenue optimization and customer engagement to healthcare payers, providers, pharmacy benefit managers, and life sciences organizations. Further, it offers predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, payment integrity and care management, and data management. The company was founded in 1999 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, ExlService Holdings has a trailing twelve months EPS of $1.
PE Ratio
ExlService Holdings has a trailing twelve months price to earnings ratio of 28.83. Meaning, the purchaser of the share is investing $28.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.55%.
6. Lakeland Industries (LAKE)
7.9% sales growth and 4.45% return on equity
Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and firefighting and heat protective apparel to protect against fire. The company also provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of approximately 1,600 safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. The company was incorporated in 1982 and is headquartered in Decatur, Alabama.
Earnings Per Share
As for profitability, Lakeland Industries has a trailing twelve months EPS of $0.71.
PE Ratio
Lakeland Industries has a trailing twelve months price to earnings ratio of 21.11. Meaning, the purchaser of the share is investing $21.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.45%.
7. Acadia Healthcare Company (ACHC)
7.5% sales growth and 9.61% return on equity
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or 24-hour observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and offer therapeutic placement for children and adolescents with emotional disorders. As of February 28, 2022, it operated a network of 228 behavioral healthcare facilities with approximately 10,500 beds. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Earnings Per Share
As for profitability, Acadia Healthcare Company has a trailing twelve months EPS of $2.93.
PE Ratio
Acadia Healthcare Company has a trailing twelve months price to earnings ratio of 24.14. Meaning, the purchaser of the share is investing $24.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.61%.
Yearly Top and Bottom Value
Acadia Healthcare Company’s stock is valued at $70.74 at 01:22 EST, way under its 52-week high of $89.85 and higher than its 52-week low of $66.87.
Moving Average
Acadia Healthcare Company’s value is below its 50-day moving average of $74.85 and below its 200-day moving average of $75.85.
